Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Immunology is a discipline of medical and biological research that studies the immune system. The immune system defends us against infection in a variety of ways. Diseases such as autoimmunity, allergies, and cancer can occur when the human immune system is not operating properly. Autoimmune diseases occur when the immune system attacks the body that it’s meant to protect. People suffering from autoimmune diseases have a defect that makes their immune system unable to distinguish 'self' from ‘non-self’ or 'foreign' molecules. Immunology provides a wide variety of laboratory tests for the detection of autoimmune diseases.

The global immunology market is estimated to be valued at US$ 91,850 Million in 2021 and is expected to reach US$ 156,378.2 million by 2028, at a CAGR of 8% during the forecast period (2021–2028).

Figure 1. Global Immunology Market Value (US$ Mn) & Y-o-Y Growth (%)

Immunology  | Coherent Market Insights

Recent product approvals by regulatory agencies is expected to drive the market growth over the forecast period.

The approval of new drugs and the trends of improvements in clinical efficiencies will bode well for the global immunology industry. For instance, the Food and Drug Administration (FDA) granted AbbVie permission to use ‘SKYRIZI' in 2019. The medication was developed to treat moderate to severe plaque psoriasis. This medication was designed to treat adults with psoriasis who had been prescribed or were receiving treatment.

Figure 2. Global Immunology Market Share, By Drug Class, 2021

Immunology  | Coherent Market Insights

Global Immunology Market – Regional Analysis

Globally North America has the largest share in immunology drug market because of the availability of better reimbursement policies, high potential to invest a huge amount of money in the development of immunology drugs, and due to the advancement of technologies. Moreover, because of the easy accessibility to immunology medications and the high affordability of therapy, Europe is the second largest region in terms of market value. Increase in awareness, rising economy, increasing government initiatives, and large patient pool in Asia-Pacific regions also demonstrate a high growth in global immunology market.

request-sample

Immunology Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 91,850 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 8% 2028 Value Projection: US$ 156,378.2 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Drug Class: Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal Antibody (pAb), Others
  • By Disease Indication: Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, Others
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Companies covered:

AbbVie Inc., Janssen Global Services, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Amgen Inc., Pfizer Inc., Novartis, Astellas, Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., UCB SA, and Allergan plc.

Growth Drivers:
  • Increasing prevalence of autoimmune disorders
  • Increasing product approvals by regulatory agencies
  • Increasing funding from the various government and non-government organizations
Restraints & Challenges:
  • High cost of immunology drugs
  • Adverse effects associated with these drugs 
  • Lack of awareness

Global Immunology Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it as a public health emergency in 2020. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, the number of COVID-19 cases reported globally as of August 2, 2021 are approximately 198,234,951 confirmed cases with around 4,227,359 deaths. The coronavirus or COVID-19 outbreak started from Wuhan, China and has spread across continents, affecting various industries globally.

The negative effect of the global pandemic, COVID-19, has been felt across several economies facing unprecedented loss, this is owing to the lockdown announced by the government agencies, due to which several industries have been at a standstill with limited operational activities. However, a collective effort from the government and the industries are likely to bring the economy back on track, and aid in the resumption of industrial activities.

Global Immunology Market: Restraint

High costs of immunology drug, adverse effects associated with these drugs, and lack of awareness are the major factors that can hinder the growth of the global immunology market. For instance, according to data reported by the New York Times from SSR health, a research firm, the price of Humira (a prescription injection used to treat rheumatoid arthritis and other conditions) has gone up from about US$ 19,000 a year (in 2012) to more than US$ 38,000 a year (in 2019) per patient.

Key Players

Major players operating in the global immunology market include AbbVie Inc., Janssen Global Services, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Amgen Inc., Pfizer Inc., Novartis, Astellas, Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., UCB SA, and Allergan plc.

The immune system is a collection of internal structures and processes that protects the body from potentially harmful foreign bodies and diseases. It recognizes and distinguishes diverse dangers such as bacteria, viruses, and parasites from the body's healthy tissues. When our immune system becomes weakened and loses its ability to recognize and eliminate aberrant cells, our bodies attack and damage their own tissues, resulting in diseases like cancer and autoimmune diseases. Immunotherapy is a treatment strategy that involves activating, strengthening, or suppressing the immune system in order to fight diseases.

There are 80 different forms of autoimmune illnesses, with rheumatoid arthritis, systemic lupus erythematosus (Lupus), juvenile rheumatoid arthritis, inflammatory bowel arthritis, and psoriatic arthritis being the most common. These autoimmune diseases affect different body organs such as joints, muscles, skin, red blood cells, blood vessels, connective tissues, and endocrine glands. Immunology drugs are one of the preferable choice of immunotherapy that is used by several oncologists as they provide long-lasting affect by activating the immune system to identify cancerous cells and kill them through the natural process & improve the quality of survival.

Market Dynamics

One of the primary factors driving the global immunology market expansion is the high frequency of autoimmune illnesses such as rheumatoid arthritis, systemic lupus erythematosus (Lupus), juvenile rheumatoid arthritis, inflammatory bowel arthritis, Psoriatic arthritis, and others. According to a research from the National Institutes of Health, up to 23.5 million Americans (almost 7% of the population) had an autoimmune disease in 2017, therefore increasing the patient pool which will ultimately boost the market.

Key features of the study:

  • This report provides in-depth analysis of the global immunology market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global immunology market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies.
  • Key companies covered as a part of this study include AbbVie Inc., Janssen Global Services, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Amgen Inc., Pfizer Inc., Novartis, Astellas, Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., UCB SA, and Allergan plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global immunology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunology market

Detailed Segmentation:

  • Global Immunology Market, By Drug Class:
    • Monoclonal Antibody (mAb)
    • Fusion Proteins
    • Immunosuppressants
    • Polyclonal Antibody (pAb)
    • Others
  • Global Immunology Market, By Disease Indication:
    • Rheumatoid Arthritis
    • Psoriatic Arthritis
    • Plaque Psoriasis
    • Ankylosing Spondylitis
    • Inflammatory Bowel Disease
    • Prophylaxis of Organ Rejection
    • Others
  • Global Immunology Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Immunology Market, By Region:
    • North America
      • By Drug Class
        • Monoclonal Antibody (mAb)
        • Fusion Proteins
        • Immunosuppressants
        • Polyclonal Antibody (pAb)
        • Others
      • By Disease Indication
        • Rheumatoid Arthritis
        • Psoriatic Arthritis
        • Plaque Psoriasis
        • Ankylosing Spondylitis
        • Inflammatory Bowel Disease
        • Prophylaxis of Organ Rejection
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Drug Class
        • Monoclonal Antibody (mAb)
        • Fusion Proteins
        • Immunosuppressants
        • Polyclonal Antibody (pAb)
        • Others
      • By Disease Indication
        • Rheumatoid Arthritis
        • Psoriatic Arthritis
        • Plaque Psoriasis
        • Ankylosing Spondylitis
        • Inflammatory Bowel Disease
        • Prophylaxis of Organ Rejection
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Drug Class
        • Monoclonal Antibody (mAb)
        • Fusion Proteins
        • Immunosuppressants
        • Polyclonal Antibody (pAb)
        • Others
      • By Disease Indication
        • Rheumatoid Arthritis
        • Psoriatic Arthritis
        • Plaque Psoriasis
        • Ankylosing Spondylitis
        • Inflammatory Bowel Disease
        • Prophylaxis of Organ Rejection
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Drug Class
        • Monoclonal Antibody (mAb)
        • Fusion Proteins
        • Immunosuppressants
        • Polyclonal Antibody (pAb)
        • Others
      • By Disease Indication
        • Rheumatoid Arthritis
        • Psoriatic Arthritis
        • Plaque Psoriasis
        • Ankylosing Spondylitis
        • Inflammatory Bowel Disease
        • Prophylaxis of Organ Rejection
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Drug Class
        • Monoclonal Antibody (mAb)
        • Fusion Proteins
        • Immunosuppressants
        • Polyclonal Antibody (pAb)
        • Others
      • By Disease Indication
        • Rheumatoid Arthritis
        • Psoriatic Arthritis
        • Plaque Psoriasis
        • Ankylosing Spondylitis
        • Inflammatory Bowel Disease
        • Prophylaxis of Organ Rejection
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Drug Class
        • Monoclonal Antibody (mAb)
        • Fusion Proteins
        • Immunosuppressants
        • Polyclonal Antibody (pAb)
        • Others
      • By Disease Indication
        • Rheumatoid Arthritis
        • Psoriatic Arthritis
        • Plaque Psoriasis
        • Ankylosing Spondylitis
        • Inflammatory Bowel Disease
        • Prophylaxis of Organ Rejection
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • AbbVie Inc.*
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Janssen Global Services,
    • Johnson & Johnson
    • Hoffmann-La Roche Ltd.
    • Amgen Inc.
    • Pfizer Inc.
    • Novartis
    • Astellas
    • Bristol-Myers Squibb Company
    • Merck Sharp & Dohme Corp.
    • UCB SA
    • Allergan plc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Class
      • Market Snapshot, By Disease Indication
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
      • Market Opportunity Map
  3. Global Immunology Market Insights
    • Drivers
    • Restraints
    • Opportunity
    • Impact Analysis
    • Pipeline Analysis
    • Market Trends
    • New Product Launches
    • Key Developments
    • Regulatory Scenario
    • Advances in R&D for Immunology
    • Collaborations & Acquisitions
    • Epidemiology
    • PEST Analysis
  4. Global Immunology Market - Impact of Coronavirus (Covid-19) Pandemic
    • Economic Impact
    • COVID-19 Epidemiology
    • Impact of COVID-19 on Immunology Market
  5. Global Immunology Market, By Drug Class, 2017 – 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Monoclonal Antibody (mAb)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Fusion Proteins
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Immunosuppressants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Polyclonal Antibody (pAb)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
  6. Global Immunology Market, By Disease Indication, 2017 – 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Rheumatoid Arthritis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Psoriatic Arthritis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Plaque Psoriasis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Ankylosing Spondylitis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Inflammatory Bowel Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Prophylaxis of Organ Rejection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
  7. Global Immunology Market, By Distribution Channel, 2017 – 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
  8. Global Immunology Market, By Region, 2017 – 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Region at Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2017–2028, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Snapshot
    • Company Profiles
      • AbbVie Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Janssen Global Services
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Johnson & Johnson
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Hoffmann-La Roche Ltd
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Amgen Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Pfizer Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Novartis
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Astellas
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bristol-Myers Squibb Company
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Merck Sharp & Dohme Corp.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • UCB SA
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Allergan plc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  10. Section
    • Research Methodology
    • About us

*Browse 35 market data tables and 36 figures on "Immunology Market” - Global forecast to 2028

FAQgrowicon

Frequently Asked Questions

The market size is estimated to be valued at US$ 91,850 Million in 2021 and is expected to exhibit a CAGR of 8% between 2021 and 2028.
Increasing prevalence of autoimmune disorders, increasing product approvals by regulatory agencies, and increasing funding from the various government and non-government organizations are the major factors driving the growth of the market.
The Monoclonal antibody segment is the leading drug class segment in the market.
High costs of immunology drug, adverse effects associated with immunology related drugs, and lack of awareness are the major factors restraining growth of the market.
Major players operating in the market includes AbbVie Inc., Janssen Global Services, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Amgen Inc., Pfizer Inc., Novartis, Astellas, Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., UCB SA, and Allergan plc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.